Selection of latest closed projects

Spirig Pharma AG’s  generic drugs /OTC drugs unit is the third-largest supplier of off-patent drugs in Switzerland. We performed a strategic analysis based on which the management of Spirig Pharma decided to focus on its...
[more]

Sale for succession reasons with a complex minority shareholder situation: P&S Vorspannsysteme AG is a leading developer, engineer and manufacturer of high-end bolting systems for the heavy machine industry. P&S was...
[more]

Divestment process and succession solution to secure further growth options: X-Compound is a profitable and innovation-driven company operating in the niche segment of Co-Kneaders for plastics compounding and chemical...
[more]